Table 3.
Cross-protective effects in 3-week-old SPF chickens immunized with K40/09 parent, K40/09 HP40 and K40/09 HP50 against challenge with three distinct subgroups of nephropathogenic IBV strain.
IBV strain immunizeda | Genogroup of challenge virus | IBV strain of challenge virusb | No. of challenge virus isolated/no.of challengedc |
|||
---|---|---|---|---|---|---|
Trachea | Kidney | |||||
Control | Vaccinated | Control | Vaccinated | |||
K40/09 (Parent) | Korean II subgroup 1 | KM91 | 10/10 | 0/10*** | 10/10 | 2/10*** |
Korean II subgroup 2 (QX-like) | K1277/03 | 10/10 | 0/10*** | 10/10 | 1/10*** | |
Korean new cluster 1 | K40/09 | 10/10 | 0/10*** | 10/10 | 0/10*** | |
K40/09 HP40 | Korean II subgroup 1 | KM91 | 10/10 | 0/10*** | 9/10 | 0/10*** |
Korean II subgroup 2 (QX-like) | K1277/03 | 10/10 | 0/10*** | 10/10 | 0/10*** | |
Korean new cluster 1 | K40/09 | 10/10 | 0/10*** | 10/10 | 1/10*** | |
K40/09 HP50 | Korean II subgroup 1 | KM91 | 10/10 | 0/10*** | 9/10 | 0/10*** |
Korean II subgroup 2 (QX-like) | K1277/03 | 10/10 | 1/10*** | 10/10 | 0/10*** | |
Korean new cluster 1 | K40/09 | 10/10 | 0/10*** | 10/10 | 0/10*** |
Three-week-old chickens were immunized with IBV K40/09 parent, K40/09 HP40 or K40/09 HP50 (103.0 EID50/bird) via the intraocular route.
At 3 weeks post-immunization, all birds were challenged with 104.5 EID50 of three challenge strains via the intraocular route.
Five days after challenge, protection was evaluated by the absence of challenge virus in the trachea and kidney.
p < 0.001, by Fisher's exact test, compared to non-vaccinated control group.